Skip to main content
. Author manuscript; available in PMC: 2014 Dec 8.
Published in final edited form as: Arch Pediatr Adolesc Med. 2009 Jul;163(7):674–675. doi: 10.1001/archpediatrics.2009.93

Table 1.

Variables at baseline and after 6 months of dietary intervention

Low Fructose Group
n=6
Mean ± se
Low Fat Group
n=4
Mean ± se
baseline follow-up baseline follow-up
Energy(kcal/day)* 1729 ± 166 1766 ± 91 2412 ± 229 1593 ± 82
Carbohydrate(% total calories) 59 ± 3 49 ± 3 52 ± 3 51 ± 4
Fructose(g) 53 ± 15 31 ± 4 43 ± 16 23 ± 4
Fat(% total calories) 31 ± 2 37 ± 2 35 ± 3 31 ± 3
Protein(% total calories) 12 ± 1 16 ± 1 14 ± 1 19 ± 2
BMI(z-score) 20 ± 0.2 1.9 ± 0.3 2.3 ± 0.2 2.3 ± 0.2
Systolic BP(mm Hg) 122.5 ± 4.0 112.3 ± 5.8 118.0 ± 3.6 127.5 ± 4.3
Diastolic BP(mm Hg) 60.7 ± 3.6 67 0 ± 3 7 66.8 ± 1.4 64.8 ± 6.4
AST(IU/L) 71.2 ± 12.2 51.0 ± 13.0 65.3 ± 25.6 51.3 ± 20.9
ALT(IU/L) 125.5 ± 22.0 83.6 ± 25.4 103.3 ± 55.6 92.5 ± 49.6
Cholesterol(mgJdL) 183.5 ± 12.5 176.3 ± 14.7 153.5 ± 7.5 160.5 ± 11.3
HDL(mg/dL) 42.8 ± 2.1 37.5 ± 3.0 45.8 ± 3.4 46.0 ± 1.7
LDL(mg/dL) 118 2 ± 10.3 115.0 ± 13.0 93.0 ± 4.5 92.8 ± 5.0
Triglycerides(mg/dL) 113.0 ± 23.2 119.8 ± 20.4 96.8 ± 13.8 108.0 ± 25.5
Oxidized LDL(U/L)** 69.2 ± 5.7 61.2 ± 5.6 59.5 ± 1.8 60.1 ± 6.3
Urinary Isoprostanes ng/ml) 5.2 ± 0.9 4.5 ± 0.5 5.5 ± 1.1 5.7 ± 0.9
*

Significant difference (p<0.05) between baseline low fructose and low fat groups (by Main Whitney U).

**

Significant difference (p<0.05) between baseline and 6 month fcllcw-up(sign test).

1

Follow up diet variables represent average of reported diet at 1. 5 and 6 months.